Nasopharyngeal cancer: epidemiology, staging, and treatment.
about
Role of chemotherapy in nasopharyngeal carcinomaConcurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Differential baseline and response profile to IFN-gamma gene transduction of IL-6/IL-6 receptor-alpha secretion discriminate primary tumors versus bone marrow metastases of nasopharyngeal carcinomas in culture.Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysisPrognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinomaPromising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.High cell density and latent membrane protein 1 expression induce cleavage of the mixed lineage leukemia gene at 11q23 in nasopharyngeal carcinoma cell line.Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in AsiaEarly detection of nasopharyngeal carcinoma.The cadherin-catenin complex in nasopharyngeal carcinomaThe Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma.The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma.State-of-the-art management of nasopharyngeal carcinoma: current and future directionsValidation of a new prognostic index score for disseminated nasopharyngeal carcinomaHead and neck cancer. An aetiopathogenetic study of non-endemic lymphoepithelioma.The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.Inhibitor of caspase-activated DNase expression enhances caspase-activated DNase expression and inhibits oxidative stress-induced chromosome breaks at the mixed lineage leukaemia gene in nasopharyngeal carcinoma cells.Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infectionRefractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical coursePoor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate-dehydrogenase activity.Diagnostic usefulness of telomerase activity in nasopharyngeal carcinoma.
P2860
Q27022454-F2E3CD03-00BD-452C-A268-9EF11B4B9235Q33395652-8D0F0D36-C560-473F-86BD-E1EFA090F00CQ33428012-D92FFD4F-6C5E-4290-A305-8F6359BC1588Q33460760-F6623EB5-E22E-46D3-BD44-A5C1E0D5FEB4Q33883005-4F6FB2B2-81E4-4E3C-8692-2B8573FA63F9Q33889391-59412406-BE3E-4C47-9E2F-D7DB71D9220CQ34149078-1D34E0A4-11FE-46D1-B120-B8D6776E20ECQ34159567-E8C6470A-1832-4342-831C-A915EFA67FA0Q34198888-AB560F88-C838-4ACA-87AF-1022E831DBB4Q34494991-89153FE9-F119-471E-84C0-4DAC0C0B121BQ35055640-40344A7D-4C0F-4D9B-9D26-372587B58D5FQ35145996-E4CD512A-554A-4304-845C-B3AA5FFE2ADEQ35495968-117F6262-767E-49A8-AA15-7AE6832ED7D7Q35587428-86A256AD-AEA8-45F3-901E-853DE2222ED8Q35597559-ED2DAE0B-4F91-404A-AA89-3BEDD6E82284Q35670921-871D1A3C-CB16-46B3-B87D-08A818AB8D06Q35894633-67C39479-E611-4C4A-8E7A-93E677EEF612Q36065641-DFEA055C-25D4-4D03-9554-A2859A8EF332Q36616746-8761B6BC-54D1-4398-BE88-0E74EDECDCCAQ36782580-98123F60-927F-4FDE-AE1E-49779925A65CQ37452295-F475C11C-1671-4290-8C6B-B0C292480F33Q41175425-21F012B6-CF4D-4C17-88DB-68183CDC5E2BQ41931140-7552E320-81B6-460A-AACC-171CC84E5B27Q42053972-5F33997C-1AC7-4B00-87A8-97527C0DB276Q43619721-42C6707A-D5F9-4CBF-99F5-3D145464BB87Q55286183-F56439DE-E4DE-4DA7-BE1C-370AAB6715C4
P2860
Nasopharyngeal cancer: epidemiology, staging, and treatment.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Nasopharyngeal cancer: epidemiology, staging, and treatment.
@en
type
label
Nasopharyngeal cancer: epidemiology, staging, and treatment.
@en
prefLabel
Nasopharyngeal cancer: epidemiology, staging, and treatment.
@en
P2093
P1433
P1476
Nasopharyngeal cancer: epidemiology, staging, and treatment
@en
P2093
P304
P577
1994-06-01T00:00:00Z